publicações selecionadas
-
artigo académico
- Seronegative Celiac Disease - A Challenging Case. Cureus. 2022
- Heart Failure: From Typical Clinical Manifestations to the Surprising Final Diagnosis. Cureus. 2022
- Portuguese Propolis Antitumoral Activity in Melanoma Involves ROS Production and Induction of Apoptosis. Biomolecules. 2022
- Portuguese Propolis Antitumoral Activity in Melanoma Involves ROS Production and Induction of Apoptosis. Biomolecules. 2022
- Useful Ultrasonographic Parameters to Predict Difficult Laryngoscopy and Difficult Tracheal Intubation-A Systematic Review and Meta-Analysis.. Frontiers in Medicine. 2021
- Replication of GWAS identifies RTEL1, CDKN2A/B, and PHLDB1 SNPs as risk factors in Portuguese gliomas patients. Molecular Biology Reports. 2020
- Effects of the functional HOTAIR rs920778 and rs12826786 genetic variants in glioma susceptibility and patient prognosis. Journal of Neuro-Oncology. 2017
- Copy Number Profiling of Brazilian Astrocytomas.. G3: Genes, Genomes, Genetics. 2016
- SPINT2 Deregulation in Prostate Carcinoma. Journal of Histochemistry & Cytochemistry. 2016
- Impact of TGF-ß1 -509C/T and 869T/C polymorphisms on glioma risk and patient prognosis. Tumor Biology. 2015
- Immunoglobulin genes implicated in glioma risk. Oncoimmunology. 2014
- Impact of EGFR genetic variants on glioma risk and patient outcome. Cancer Epidemiology Biomarkers & Prevention. 2011
- Microsatellite instability in pediatric high grade glioma is associated with genomic profile and differential target gene inactivation 2011
- Low frequency of MAP kinase pathway alterations in KIT and PDGFRA wild-type GISTs. Histopathology. 2009
-
capítulo de livro
-
documento
- Uncovering a novel modulator of cancer metabolism and BRAF inhibitor sensitivity in melanoma 2025
- Relevance of WNT6 in Extracellular Vesicles of Glioblastoma: Clinical and Molecular Insights 2024
- SPINT2 reduces melanoma aggressiveness and improves therapeutic response 2024
- Exploiting the Relevance of WNT6 in Extracellular Vesicles of Glioblastoma: Clinical and Molecular Insights 2024
- SPINT2 downregulation increases melanoma aggressiveness features 2022
- SPINT2: a potential biomarker for melanoma patients 2021
- SPINT2 downregulation in Melanoma influences EMT 2021
- SPINT2 role and therapeutic influence in Melanoma 2020
- Paper-based platform with an in situ molecularly imprinted polymer for ß-amyloid. ACS Omega. 2020
- Abstract P15: SPINT2 as a therapeutic biomarker in Melanoma 2019
- Study of functional role and therapeutic influence of the tumor suppressor gene SPINT2 in Melanoma 2018
- Step towards simulation and monitoring of hospital waiting lists 2012
- Analysis of MAP kinase signalling pathway in KIT & PDGFRA wild-type GISTs. 2008